The phosphatidylinositol (PI) hydrolysis signaling system has been shown to be altered in platelets of depressed and schizophrenic subjects. Inositol (1,4,5) trisphosphate (Ins(1,4,5)P 3 ), an integral component of the PI signaling system, mobilizes Ca 2+ by activating Ins(1,4,5)P 3 receptors. To eventually investigate the role of Ins(1,4,5)P 3 receptors in depression and other mental disorders, we characterized [ 3 H]Ins(1,4,5)P 3 binding sites in crude platelet membranes prepared from small amounts of blood obtained from healthy human control subjects. We found a single, saturable binding site for [ 3 H]Ins(1,4,5)P 3 to crude platelet membranes, which is time dependent and modulated by pH, inositol phosphates, and heparin. Since cyclic adenosine monophosphate (cAMP) and Ca 2+ have been shown to be important modulators in Ins(1,4,5)P 3 receptors, in the present study we also determined the effects of various concentrations of CaCI 2 and forskolin on Ins(1,4,5)P 3 binding to platelet membranes. 
Introduction
Agonist-stimulated activation of cell surface receptors, such as 5HT 2A , 5HT 2C , α adrenergic, and muscarinic receptors, leads to the hydrolysis of phosphatidylinositol 4,5-bisphosphate by stimulating phospholipase C (PLC) and subsequently generating two second messengers: diacylglycerol (DG) and inositol 1,4,5-trisphosphate (Ins(1,4,5)P 3 ). DG activates protein kinase C (PKC) [1] , while Ins(1,4,5) P 3 triggers the release of Ca 2+ from intracellular sources by interacting with Ins(1,4,5)P 3 receptors [2] [3] [4] . Ins(1,4,5)P 3 receptors have been identified and characterized in both central and peripheral tissues, such as the brain [5] , the hepatic plasma membranes [6] , smooth muscle cells [7, 8] , rat cerebral and bovine adrenocortical membranes [9] , and the rat cerebellum [10] . Cloning studies in various tissues show the existence of three types (I, II, and III) of Ins(1,4,5)P 3 receptors [11] [12] [13] . All are believed to act as Ca 2+ channels [4, 14] .
Similar to other cell types, Ins(1,4,5)P 3 in platelets also functions as a second messenger and mobilizes calcium (Ca 2+ ) by activating the Ins(1,4,5)P 3 receptor site [15, 16] , which plays an important role in platelet responses involved in homeostasis and thrombosis. Platelets offer a suitable peripheral model for studying abnormalities in neurotransmitter receptors and receptor-mediated second messenger systems such as adenylyl cyclase-cyclic adenosine monophosphate (cAMP) and the phosphatidyl inositol (PI) hydrolysis signaling system. Some reports indicate that the PI signaling system is altered in the platelets of depressed and schizophrenic subjects. Kaiya et al. [17] showed an increase in DG in the platelets of schizophrenic subjects and proposed that this increase may cause a decrease in Ins(1,4,5)P 3 /Ca 2+ function. Also Mikuni et al. [18] reported an increase in 5HT-induced accumulation of inositol phosphate-1 (IP 1 ) in the platelets of depressed patients compared to control subjects. We also observed that thrombin-stimulated IP 1 receptors formation was significantly greater in depressed patients compared to control subjects [19] . Since the abovementioned studies indicate abnormalities in the PI signaling system in depression, it is quite possible that these abnormalities may also be associated with alterations in Ins(1,4,5)P 3 receptors. Therefore, it is important to examine Ins(1,4,5)P 3 receptors in the platelets of these subjects. So far, the role of Ins(1,4,5)P 3 receptors in platelets of patients with mental disorders has not been studied. To eventually examine if Ins(1,4,5)P 3 receptors are altered in depressed subjects and patients with other mental disorders, we characterized Ins(1,4,5)P 3 receptors in crude platelet membranes obtained from normal human control subjects. Although Ins(1,4,5)P 3 receptors have been characterized in purified intracellular human platelet membranes rich in dense tubular systems [20] , for clinical studies it is important to examine if Ins(1,4,5)P 3 receptors can be studied in crude membranes since it is not feasible to obtain large amounts of blood from patient populations. Ca 2+ and cAMP are two potent modulators in Ins(1,4,5)P 3 receptors in various tissues (5, 21, 22, 23 
Preparation of Platelet
Membranes. Blood (10 to 20 mL) was drawn from healthy normal human subjects into a tube containing 3.8% (w/v) sodium citrate. The blood was centrifuged immediately at 210 × g for 10 minutes at 4
• C to obtain platelet-rich plasma (PRP), which was centrifuged at 4000 × g for 10 minutes at 4
• C. The platelet pellet thus obtained was homogenized by polytron (at #7 setting) for 30 seconds in a homogenizing buffer containing 50 mM Tris-HCl, pH 7.7; 1 mM ethylene diamine N , N , N , Ntetraacetic acid (EDTA); and 2 mM 2-mercaptoethanol. The homogenate was centrifuged at 40,000 × g for 15 minutes at 4
• C. The supernatant was discarded and the pellet was homogenized once again in the homogenizing buffer and centrifuged as described above. The resulting pellet was resuspended in a buffer containing 50 mM Tris-HCl, pH 8.5; 1 mM EDTA; and 1 mM 2-mercaptoethanol. This fraction was used for the [ 3 H]Ins(1,4,5)P 3 binding assay. To examine the effect of CaCl 2 , the binding assay was performed in presence or absence of EDTA, as described below. (1, 4, 5) 3 (specific activity 21 Ci/mmol) ranging from 10 to 100 nM (six different concentrations), and 40 μL of platelet membrane suspension in a total volume of 100 μL. Nonspecific binding was determined in the presence of 10 μM Ins(1,4,5)P 3 . The incubation was performed at 4
[ 3 H]Ins
• C for 10 minutes and rapidly terminated by the addition of 5 mL of cold buffer (50 mM Tris-HCl, pH 7.7; 1 mM EDTA; and 0.1% (w/v) bovine serum albumin) and filtration through Whatman GF/B filters. The filter-bound radioactivity was analyzed by a liquid scintillation counter. Specific binding was defined 
Determination of the Effect of CaCl 2 on [ 3 H]Ins(1,4,5)P 3
Binding. The effects of CaCl 2 were studied in the presence and in the absence of EDTA. Platelet membranes (100 μg protein) were incubated with CaCl 2 (0.5 to 30 mM) in a buffer containing 50 mM Tris-HCl, pH 8.5; 1 mM 2 mercaptoethanol; and 20 mM [ 3 H]Ins(1,4,5)P 3 . EDTA (1 mM) was added to the incubation medium in which the effect of CaCl 2 was studied in the presence of EDTA. The incubation was carried out at 4
• C for 10 minutes.
Determination of the Effect of Forskolin on [ 3 H]Ins(1,4, 5)P 3
Binding. Platelet protein samples (100 μg) were incubated with forskolin (10 −4 to 10 −6 M) in a buffer containing 50 mM Tris-HCl, pH 8.5; 1 mM EDTA; and 1 mM 2-mercaptoethanol. The incubation was carried out at 4
• C for 10 minutes. (1, 4, 5 
Results

pH-Dependence of [ 3 H]Ins
Effects of CaCl 2 on [ 3 H]Ins(1,4,5)P 3 Binding to Platelet
Membranes. Ca 2+ has been shown to be a potent modulator of [ 3 H]Ins(1,4,5)P 3 receptors. In the present investigation, 
Discussion
The pharmacological properties of Ins(1,4,5)P 3 receptors have been characterized in several tissues including the brain [5, 8] . In an earlier study, Varney et al. [24] Time-course experiments revealed that maximum binding occurred at 2 minutes and remained stable up to 60 minutes. We determined IC 50 values of different inositol phosphates in crude platelets membranes. D-Ins(1,4,5)P 3 was found to be the most potent, with an IC 50 value of 0.3 μM. Heparin is a competitive antagonist of the Ins(1,4,5)P 3 receptor [5] . In the present study, heparin inhibited [ 3 H]Ins(1,4,5)P 3 binding in a concentration-dependent manner, with an IC 50 value of 36.79 μg/mL. These pharmacological properties of Ins(1,4,5)P 3 receptors in crude platelet membranes were found to be similar to those reported in other tissues [5, 8] . Earlier, Hwang [20] characterized [ 3 H]Ins(1,4,5)P 3 receptors in purified human platelet membranes rich in dense tubular systems. In this fraction of platelet membranes, Hwang reported two binding sites of [ 3 H]Ins(1,4,5)P 3 , one with low affinity, and another with high affinity; however in our study, we observed only one binding site in crude platelet membranes, which is very similar to that reported by Varney et al. [24] . One binding site has also been reported in other tissues [6, 10, 25] . It is quite possible that the explanation of the single binding site observed by us and Varney et al. in crude platelet membranes and the two binding sites observed by Hwang in purified platelet membranes may be the differences in the preparation of platelet membranes. The pH-and the time-course profiles observed in the present study are similar to those reported in other tissues, including platelets [5, 7, 9, 20] .
In continuation of our study, we further investigated the effects of agents that are known to modulate Ins(1,4,5)P 3 receptors. One such agent is Ca 2+ , which has been shown to affect [ 3 H]Ins(1,4,5)P 3 binding in most tissues [5, 25, 26] . In the present investigation, we studied the effects of various concentrations of CaCl 2 on [ 3 H]Ins(1,4,5)P 3 binding to crude platelet membranes. Since EDTA is known to chelate Ca 2+ and our incubation medium contained 1 mM EDTA, we studied the effects of CaCl 2 in the presence and in the absence of EDTA. We observed that CaCl 2 stimulated The mechanism by which Ca 2+ inhibits [ 3 H]Ins(1,4,5)P 3 binding in platelets is presently unclear. Delfert et al. [27] reported an inhibitory effect in the release of Ca 2+ from the endoplasmic reticulum in the presence of free Ca 2+ . It is possible that Ca 2+ itself regulates the further release of Ca 2+ by inhibiting Ins(1,4,5)P 3 binding. Danoff et al. [28] hypothesized that the inhibitory effect of Ca 2+ is mediated by a protein called calmedin in the cerebral membranes of rats; while Mignery et al. [29] suggested that Ca 2+ -induced inhibition is mediated by Ca 2+ -activated PLC, which produces additional Ins (1, 4, 5 In summary, our study shows a single, saturable binding site for [ 3 H]Ins(1,4,5)P 3 in crude platelet membranes, which is time dependent and modulated by pH, inositol phosphates, heparin, Ca 2+ , and cAMP. Although there is a minor difference between the results obtained in crude platelet membranes in this study as compared to the results in purified platelet membranes, the pharmacological These results are important, especially considering that due to the difficulty of obtaining large-enough samples of blood from patients, preparation of purified platelet membranes is not feasible for clinical research. Since the preparation of crude platelet membranes is convenient and requires a smaller amount of blood, this procedure can be utilized to study the role of Ins(1,4,5)P 3 receptors in depression and other mental disorders, such as schizophrenia or bipolar disorders. Even, within a specific diagnosis, measuring IP3 receptors may be helpful in distinguishing subtypes of mental illness. For example, it will be interesting to examine whether IP3 receptors are altered in a subset of depressed patients. In this regard, the prime example is protein kinase A, which has been shown to be altered in a subtype of depressed patients, that is, melancholic depressed patients or patients who committed suicide [33, 34] . Thus, measuring IP3 receptors in blood cells may lead to the development of novel interventions that could target specific points of vulnerability. 
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